It was similar to the results of Jiang et al. [17], who found that VEGFR-2 also played a key role in tumor formation, indicating that Spiriva combined with Symbicort could effectively reduce the level of VEGFR-2 and promote the immunologic function of NSCLC. This evidence concerns the gene KDR and neoplasm.